Literature DB >> 24361302

Ubiquitin-conjugating enzyme E2C: a potential cancer biomarker.

Chanlu Xie1, Chris Powell1, Mu Yao2, Jianmin Wu3, Qihan Dong4.   

Abstract

The ubiquitin-conjugating enzymes 2C (UBE2C) is an integral component of the ubiquitin proteasome system. UBE2C consists of a conserved core domain containing the catalytic Cys residue and an N-terminal extension. The core domain is required for ubiquitin adduct formation by interacting with the ubiquitin-fold domain in the E1 enzyme, and contributes to the E3 enzyme binding. UBE2C N-terminal extension regulates E3 enzyme activity as a part of an intrinsic inhibitory mechanism. UBE2C is required for the destruction of mitotic cyclins and securin, which are essential for spindle assembly checkpoint and mitotic exit. The UBE2C mRNA and/or protein levels are aberrantly increased in many cancer types with poor clinical outcomes. Accumulation of UBE2C stimulates cell proliferation and anchorage-independent growth. UBE2C transgenic mice are prone to develop spontaneous tumors and carcinogen-induced tumor with evidence of chromosome aneuploidy.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  3(10); 3(10)-helix; APC/C; ATRA; Anaphase-promoting complex; B1-4; BUB receptor 1; BUB3; BubR1; CCI-779; CDC20; CDK; CP1A/C; Cancer; Cdh1; D-box; DUBs; E1; E2; E2F; E3; G(1); G(2); H1-4; JNK; Jun N-terminal kinases; KEN-box; M; MAD 2; MED1; Meis-1; N-terminal; NF-1; NIH3T3; Pax-2; QNP; RING; RWD; S; S-phase kinase-associated protein 2; SCF; SRF; Skp1-Cullin-Fox complex; Skp2; UBE2C; UPS; USP44; UbcH10; Ubiquitin-conjugating enzymes 2C; Ubiquitination; all-trans retinoic acid; amino acid-terminal; anaphase-promoting complex/cyclosome; avian myelocytomatosis virus oncogene cellular homolog; budding uninhibited by benzimidazoles 3; c-Myc; c-Rel; cadherin-1; calpain-1 A/C; cell cycle inhibitor-779; cell division cycle 20; cyclin-dependent kinase; destruction box; deubiquitination enzymes; domain, domain find in RING finger-WD repeat domain containing protein; elongation 2 transcription factor; finger domain, really interesting new gene finger domain; gap 1 phase; gap 2 phase; human ubiquitin-conjugating enzyme 10; mRNA; mediator-1; messenger ribonucleic acid; mitosis phase; mitotic arrest deficient-like 2; motif, Gln(4), Asn(5) and Pro(8) motif; myeloid ecotropic viral integration site 1; neurofibromin 1; paxillin 2; primary mouse embryonic fibroblast; reticuloendotheliosis oncogene cellular homolog; serum response factor; synthesis phase; the amino acid sequence KEN(X)(n)P; ubiquitin ligase; ubiquitin proteasome system; ubiquitin specific peptidase 44; ubiquitin-activating enzyme; ubiquitin-conjugating enzyme; ubiquitin-conjugating enzyme E2; α-helices; β-sheets

Mesh:

Substances:

Year:  2013        PMID: 24361302     DOI: 10.1016/j.biocel.2013.11.023

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  40 in total

1.  Solution structure of the zinc finger domain of human RNF144A ubiquitin ligase.

Authors:  Kazuhide Miyamoto; Kaori Migita; Kazuki Saito
Journal:  Protein Sci       Date:  2020-07-13       Impact factor: 6.725

2.  [RNA interference of HERC4 inhibits proliferation, apoptosis and migration of cervical cancer Hela cells].

Authors:  Min Wei; Yan-Ling Zhang; Lan Chen; Cui-Xia Cai; Han-Duo Wang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2016-02-20

3.  Unique auto-ubiquitination activities of artificial RING fingers in cancer cells.

Authors:  Kazuhide Miyamoto; Arisa Nakatani; Mayumi Sunagawa; Kazuki Saito
Journal:  Protein Sci       Date:  2018-09-24       Impact factor: 6.725

4.  Identification of the inhibitor of growth protein 4 (ING4) as a potential target in prostate cancer therapy.

Authors:  Aymen Shatnawi; Sridhar A Malkaram; Tamer Fandy; Efrosini Tsouko
Journal:  Mol Cell Biochem       Date:  2019-11-27       Impact factor: 3.396

5.  Application of weighted gene co-expression network analysis to identify the hub genes in H1N1.

Authors:  Bo Sun; Xiang Guo; Xue Wen; Yun-Bo Xie; Wei-Hua Liu; Gui-Fen Pang; Lin-Ying Yang; Qing Zhang
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2021-06-15

Review 6.  Aurea mediocritas: the importance of a balanced genome.

Authors:  Gianluca Varetti; David Pellman; David J Gordon
Journal:  Cold Spring Harb Perspect Biol       Date:  2014-09-18       Impact factor: 10.005

7.  Lentivirus-mediated RNA interference targeting UbcH10 reduces cell growth and invasion of human osteosarcoma cells via inhibition of Ki-67 and matrix metalloproteinases.

Authors:  Shan-Tao Wang; Dan-Zhi Li; Jian-Min Li; Jun Fang; Hua-Zhuang Li; Pei-Jian Tong; Fu-Cun Liu
Journal:  Oncol Lett       Date:  2015-03-10       Impact factor: 2.967

8.  Expression and prognostic signatures of m6A-related lncRNAs in hepatocellular carcinoma.

Authors:  Kenan Hao; Jincheng Li; Youao Zhang; Wei Zhao; Xiaojing Chen; Jiabin Xu; Ye Tian; Xinmin Li; Jianyu Fen; Xiaofeng He
Journal:  J Cancer Res Clin Oncol       Date:  2022-09-19       Impact factor: 4.322

9.  UBE2S is associated with malignant characteristics of breast cancer cells.

Authors:  Akter Khondker Ayesha; Toshinori Hyodo; Eri Asano; Naoki Sato; Mohammed A Mansour; Satoko Ito; Michinari Hamaguchi; Takeshi Senga
Journal:  Tumour Biol       Date:  2015-08-06

10.  UBE2O Promotes Progression and Epithelial-Mesenchymal Transition in Head and Neck Squamous Cell Carcinoma.

Authors:  Xiyu Chen; Shuiting Zhang; Chao Liu; Guo Li; Shanhong Lu; Yunyun Wang; Xin Zhang; Donghai Huang; Yuanzheng Qiu; Yong Liu
Journal:  Onco Targets Ther       Date:  2020-06-29       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.